Resultados da pesquisa - Ciruelos, Eva

Standard Neoadjuvant Treatment in Early/Locally Advanced Breast Cancer Por Pernaut, Cristina, Lopez, Flora, Ciruelos, Eva

Obter o texto integral Obter o texto integral Obter o texto integral

Ribociclib-Related Stevens–Johnson Syndrome: Oncologic Awareness, Case Report, and Literature Review Por López-Gómez, Victoria, Yarza, Ramón, Muñoz-González, Héctor, Revilla, Enrique, Enrech, Santos, González-Valle, Olga, Tolosa, Pablo, Ciruelos, Eva

Obter o texto integral Obter o texto integral Obter o texto integral

Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its ap... Por Ciruelos, Eva, Alba, Emilio, López, Rafael, Lluch, Anna, Martín, Miguel, Arroyo, Isabel, Navarro, Beatriz, Carcedo, David, Colomer, Ramón, Albanell, Joan

Obter o texto integral Obter o texto integral Obter o texto integral

Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases Por Laimito, Katerin Rojas, Gámez-Pozo, Angelo, Sepúlveda, Juan, Manso, Luis, López-Vacas, Rocío, Pascual, Tomás, Fresno Vara, Juan A, Ciruelos, Eva

Obter o texto integral Obter o texto integral Obter o texto integral

The role of CDK4/6 inhibitors in early breast cancer Por Gil-Gil, Miguel, Alba, Emilio, Gavilá, Joaquín, de la Haba-Rodríguez, Juan, Ciruelos, Eva, Tolosa, Pablo, Candini, Daniele, Llombart-Cussac, Antonio

Obter o texto integral Obter o texto integral Obter o texto integral

Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer Por Pascual, Tomas, Apellániz-Ruiz, María, Pernaut, Cristina, Cueto-Felgueroso, Cecilia, Villalba, Pablo, Álvarez, Carlos, Manso, Luis, Inglada-Pérez, Lucia, Robledo, Mercedes, Rodríguez-Antona, Cristina, Ciruelos, Eva

Obter o texto integral Obter o texto integral Obter o texto integral

Everolimus plus Exemestane for Hormone Receptor‐Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO‐2 Por Prat, Aleix, Brase, Jan Christoph, Cheng, Yuan, Nuciforo, Paolo, Paré, Laia, Pascual, Tomás, Martínez, Débora, Galván, Patricia, Vidal, Maria, Adamo, Barbara, Hortobagyi, Gabriel N., Baselga, José, Ciruelos, Eva

Obter o texto integral Obter o texto integral Obter o texto integral

Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance Por Manso, Luis, Mourón, Silvana, Tress, Michael, Gómez-López, Gonzalo, Morente, Manuel, Ciruelos, Eva, Rubio-Camarillo, Miriam, Rodriguez-Peralto, Jose Luis, Pujana, Miguel A., Pisano, David G., Quintela-Fandino, Miguel

Obter o texto integral Obter o texto integral Obter o texto integral

Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study Por Corona, Silvia P., Giudici, Fabiola, Jerusalem, Guy, Ciruelos, Eva, Strina, Carla, Sirico, Marianna, Bernocchi, Ottavia, Milani, Manuela, Dester, Martina, Ziglioli, Nicoletta, Barbieri, Giuseppina, Cervoni, Valeria, Montemurro, Filippo, Generali, Daniele

Obter o texto integral Obter o texto integral Obter o texto integral

Overall survival benefit with pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer in CLEOPATRA, a randomised Phase 3 study Por Swain, Sandra M., Kim, Sung-Bae, Cortés, Javier, Ro, Jungsil, Semiglazov, Vladimir, Campone, Mario, Ciruelos, Eva, Ferrero, Jean-Marc, Schneeweiss, Andreas, Knott, Adam, Clark, Emma, Ross, Graham, Benyunes, Mark C., Baselga, José

Obter o texto integral Obter o texto integral Obter o texto integral

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer Por Swain, Sandra M., Baselga, José, Kim, Sung-Bae, Ro, Jungsil, Semiglazov, Vladimir, Campone, Mario, Ciruelos, Eva, Ferrero, Jean-Marc, Schneeweiss, Andreas, Heeson, Sarah, Clark, Emma, Ross, Graham, Benyunes, Mark C., Cortés, Javier

Obter o texto integral Obter o texto integral Obter o texto integral

Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics Por Gámez-Pozo, Angelo, Trilla-Fuertes, Lucía, Prado-Vázquez, Guillermo, Chiva, Cristina, López-Vacas, Rocío, Nanni, Paolo, Berges-Soria, Julia, Grossmann, Jonas, Díaz-Almirón, Mariana, Ciruelos, Eva, Sabidó, Eduard, Espinosa, Enrique, Fresno Vara, Juan Ángel

Obter o texto integral Obter o texto integral Obter o texto integral

Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Fina... Por Gil-Gil, Miguel J., Bellet, Meritxell, Bergamino, Milana, Morales, Serafín, Barnadas, Agustí, Manso, Luís, Saura, Cristina, Fernández-Ortega, Adela, Garcia-Martinez, Elena, Martinez-Jañez, Noelia, Melé, Mireia, Villagrasa, Patricia, Celiz, Pamela, Perez Martin, X., Ciruelos, Eva, Pernas, Sonia

Obter o texto integral Obter o texto integral Obter o texto integral

Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer Por Rojas L, Katerin, Trilla-Fuertes, Lucía, Gámez-Pozo, Angelo, Chiva, Cristina, Sepúlveda, Juan, Manso, Luis, Prado-Vázquez, Guillermo, Zapater-Moros, Andrea, López-Vacas, Rocío, Ferrer-Gómez, María, Mendiola, César, Espinosa, Enrique, Sabidó, Eduard, Ciruelos, Eva, Vara, Juan Ángel Fresno

Obter o texto integral Obter o texto integral Obter o texto integral

A Pilot, Phase II, Randomized, Open‐Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab‐Paclitaxel to That of Solvent‐Based Paclitaxel as the First‐Line... Por Ciruelos, Eva, Apellániz‐Ruiz, María, Cantos, Blanca, Martinez‐Jáñez, Noelia, Bueno‐Muiño, Coralia, Echarri, Maria‐Jose, Enrech, Santos, Guerra, Juan‐Antonio, Manso, Luis, Pascual, Tomas, Dominguez, Cristina, Gonzalo, Juan‐Francisco, Sanz, Juan‐Luis, Rodriguez‐Antona, Cristina, Sepúlveda, Juan‐Manuel

Obter o texto integral Obter o texto integral Obter o texto integral

Mouse p53-Deficient Cancer Models as Platforms for Obtaining Genomic Predictors of Human Cancer Clinical Outcomes Por Dueñas, Marta, Santos, Mirentxu, Aranda, Juan F., Bielza, Concha, Martínez-Cruz, Ana B., Lorz, Corina, Taron, Miquel, Ciruelos, Eva M., Rodríguez-Peralto, José L., Martín, Miguel, Larrañaga, Pedro, Dahabreh, Jubrail, Stathopoulos, George P., Rosell, Rafael, Paramio, Jesús M., García-Escudero, Ramón

Obter o texto integral Obter o texto integral Obter o texto integral

Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study Por Schettini, Francesco, Sobhani, Navid, Ianza, Anna, Triulzi, Tiziana, Molteni, Alfredo, Lazzari, Maria Chiara, Strina, Carla, Milani, Manuela, Corona, Silvia Paola, Sirico, Marianna, Bernocchi, Ottavia, Giudici, Fabiola, Cappelletti, Maria Rosaria, Ciruelos, Eva, Jerusalem, Guy, Loi, Sherine, Fox, Stephen B., Generali, Daniele

Obter o texto integral Obter o texto integral Obter o texto integral

Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded populati... Por De Laurentiis, Michelino, Borstnar, Simona, Campone, Mario, Warner, Ellen, Bofill, Javier Salvador, Jacot, William, Dent, Susan, Martin, Miguel, Ring, Alistair, Cottu, Paul, Lu, Janice, Ciruelos, Eva, Azim, Hamdy A., Chatterjee, Sanjoy, Zhou, Katie, Wu, Jiwen, Menon-Singh, Lakshmi, Zamagni, Claudio

Obter o texto integral Obter o texto integral Obter o texto integral

Correction to: Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an ex... Por De Laurentiis, Michelino, Borstnar, Simona, Campone, Mario, Warner, Ellen, Bofill, Javier Salvador, Jacot, William, Dent, Susan, Martin, Miguel, Ring, Alistair, Cottu, Paul, Lu, Janice, Ciruelos, Eva, Azim, Hamdy A., Chatterjee, Sanjoy, Zhou, Katie, Wu, Jiwen, Menon-Singh, Lakshmi, Zamagni, Claudio

Obter o texto integral Obter o texto integral Obter o texto integral

Early detection of anthracycline‐ and trastuzumab‐induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters Por Díaz‐Antón, Belén, Madurga, Rodrigo, Zorita, Blanca, Wasniewski, Samantha, Moreno‐Arciniegas, Andrea, López‐Melgar, Beatriz, Ramírez Merino, Natalia, Martín‐Asenjo, Roberto, Barrio, Patricia, Amado Escañuela, Maximiliano German, Solís, Jorge, Parra Jiménez, Francisco Javier, Ciruelos, Eva, Castellano, José María, Fernández‐Friera, Leticia

Obter o texto integral Obter o texto integral Obter o texto integral